Simplex Trading
SGMO

Simplex Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Simplex Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.9K Sell
149,400
-283,100
-65% -$113K ﹤0.01% 6180
2025
Q4 		$182K Buy
432,500
+21,200
+5% +$11.2K ﹤0.01% 4323
2025
Q3 		$276K Buy
411,300
+298,400
+264% +$161K ﹤0.01% 4579
2025
Q2 		$61K Sell
112,900
-24,300
-18% -$14.4K ﹤0.01% 5737
2025
Q1 		$90K Buy
137,200
+57,500
+72% +$60.9K ﹤0.01% 5168
2024
Q4 		$81K Buy
79,700
+69,000
+645% +$126K ﹤0.01% 5386
2024
Q3 		$9K Buy
10,700
+3,900
+57% +$2.86K ﹤0.01% 7280
2024
Q2 		$2K Sell
6,800
-3,100
-31% -$1.68K ﹤0.01% 8345
2024
Q1 		$6K Sell
9,900
-800
-7% -$580 ﹤0.01% 7940
2023
Q4 		$5K Sell
10,700
-100
-0.9% -$46 ﹤0.01% 7900
2023
Q3 		$6K Buy
10,800
+2,200
+26% +$2.36K ﹤0.01% 7569
2023
Q2 		$11K Sell
8,600
-17,800
-67% -$24.3K ﹤0.01% 7343
2023
Q1 		$46K Sell
26,400
-4,600
-15% -$13.1K ﹤0.01% 6018
2022
Q4 		$97K Buy
31,000
+1,700
+6% +$6.6K ﹤0.01% 5117
2022
Q3 		$143K Sell
29,300
-12,000
-29% -$61.6K ﹤0.01% 5037
2022
Q2 		$170K Sell
41,300
-22,700
-35% -$98.2K ﹤0.01% 4818
2022
Q1 		$371K Sell
64,000
-61,800
-49% -$367K ﹤0.01% 4252
2021
Q4 		$943K Buy
125,800
+75,500
+150% +$656K ﹤0.01% 2941
2021
Q3 		$604K Hold
50,300
– – ﹤0.01% 3807
2021
Q2 		$602K Buy
+50,300
New +$570K ﹤0.01% 3876
2021
Q1 		– Sell
-1,115
Closed -$1.74M – 9897
2020
Q4 		$1.74M Buy
1,115
+174
+18% +$2.04K ﹤0.01% 1917
2020
Q3 		$889K Sell
941
-765
-45% -$8.27K ﹤0.01% 2362
2020
Q2 		$1.53M Buy
1,706
+854
+100% +$7.92K ﹤0.01% 1746
2020
Q1 		$542K Sell
852
-1,025
-55% -$7.61K ﹤0.01% 2505
2019
Q4 		$1.57M Buy
1,877
+1,218
+185% +$11.2K ﹤0.01% 1693
2019
Q3 		$596K Sell
659
-28
-4% -$314 ﹤0.01% 2432
2019
Q2 		$739K Sell
687
-1,647
-71% -$17.5K ﹤0.01% 2198
2019
Q1 		$2.23M Buy
2,334
+990
+74% +$10.1K 0.01% 1283
2018
Q4 		$1.54M Sell
1,344
-59
-4% -$733 ﹤0.01% 1276
2018
Q3 		$2.38M Buy
1,403
+864
+160% +$13.1K 0.01% 1104
2018
Q2 		$765K Buy
539
+51
+10% +$847 ﹤0.01% 2029
2018
Q1 		$143K Sell
488
-752
-61% -$16.1K 0.01% 1503
2017
Q4 		$659K Sell
1,240
-34
-3% -$506 0.03% 579
2017
Q3 		$834K Sell
1,274
-323
-20% -$3.57K 0.03% 436
2017
Q2 		$362K Buy
1,597
+40
+3% +$257 0.02% 837
2017
Q1 		$126K Buy
1,557
+671
+76% +$2.69K 0.01% 1548
2016
Q4 		$30K Buy
886
+65
+8% +$237 ﹤0.01% 2655
2016
Q3 		$47K Buy
821
+311
+61% +$1.58K ﹤0.01% 2168
2016
Q2 		$15K Buy
510
+74
+17% +$472 ﹤0.01% 3180
2016
Q1 		$20K Sell
436
-348
-44% -$2.09K ﹤0.01% 2813
2015
Q4 		$27K Buy
784
+499
+175% +$3.85K ﹤0.01% 2447
2015
Q3 		$7K Buy
285
+131
+85% +$1.08K ﹤0.01% 3760
2015
Q2 		$10K Buy
154
+45
+41% +$580 ﹤0.01% 3069
2015
Q1 		$22K Buy
109
+43
+65% +$665 ﹤0.01% 2262
2014
Q4 		$27K Buy
+66
New +$801 ﹤0.01% 1828

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Simplex Trading's SGMO Position: Q4 2025 in Review

Simplex Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 9,609 shares — an estimated $5.09K sold.

Simplex Trading first reported a position in SGMO in Q4 2014 and held it in 36 quarters. The position peaked at $957K in Q1 2018. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • Simplex Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 9,609 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $5.09K.
  • Simplex Trading first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 36 quarters.
  • Simplex Trading's SANGAMO THERAPEUTICS INC position peaked at $957K in Q1 2018.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.